XILIS
Xilis is an oncology and precision health company that diagnoses cancer and finds the right treatment. The company uses “micro-organoids” to make thousands of 3D replicas of a patient’s tumor in about six days, which the company says can be used for testing for drug compatibility faster. It was founded in 2019 and is headquartered in Durham, North Carolina.
XILIS
Industry:
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.xilis.com
Total Employee:
11+
Status:
Active
Total Funding:
92 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Amazon Virginia Region Amazon S3 CDN DMARC Atlassian Cloud Google DNS Google Domains Google Cloud DNS
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Current Advisors List
Advisor
Advisor
Advisor
Advisor
Advisor
Advisor
Board_observer
2021-01-01
Current Employees Featured
Lexi McClain Business Development Associate @ Xilis
Business Development Associate
Sehwa Oh Laboratory Technical Associate @ Xilis
Laboratory Technical Associate
Stan Skrzypczak Chief Business Officer @ Xilis
Chief Business Officer
Dan Freed Founding Principal Scientist @ Xilis
Founding Principal Scientist
Xiling Shen Co-Founder, Chief Executive Officer & Board Member @ Xilis
Co-Founder, Chief Executive Officer & Board Member
Richard McGivney Chief Financial Officer @ Xilis
Chief Financial Officer
David Hsu Co-Founder & Board Member @ Xilis
Co-Founder & Board Member
David Eklund Lead, Software Engineering @ Xilis
Lead, Software Engineering
Hans Clevers Chief Scientist and Co-Founder @ Xilis
Chief Scientist and Co-Founder
Jerrin Gause Senior Operations Associate @ Xilis
Senior Operations Associate
Founder
Investors List
FPV Ventures
FPV Ventures investment in Series A - Xilis
EQT
EQT investment in Series A - Xilis
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Xilis
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series A - Xilis
GV
GV investment in Series A - Xilis
Alix Ventures
Alix Ventures investment in Series A - Xilis
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Xilis
Felicis Ventures
Felicis Ventures investment in Series A - Xilis
Duke Angel Network
Duke Angel Network investment in Series A - Xilis
Catalio Capital Management
Catalio Capital Management investment in Series A - Xilis
Official Site Inspections
http://www.xilis.com Semrush global rank: 584.13 K Semrush visits lastest month: 78.96 K
- Host name: 77.76.206.35.bc.googleusercontent.com
- IP address: 35.206.76.77
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Xilis"
Xilis - Crunchbase Company Profile & Funding
Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's …See details»
About Us - Xilis
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the …See details»
Leadership - Xilis
Roy Smythe, M.D. served as Executive Operating Chair of Xilis prior to assuming the role of CEO and Board Chair, and is also a Venture Partner for the Mubadala Investments Corporation of …See details»
Xilis 2025 Company Profile: Valuation, Funding & Investors
Xilis General Information Description. Developer of micro-organ sphere technology designed to guide precision therapy for cancer patients and accelerate drug discovery. The company's …See details»
Xilis Org Chart + Executive Team - The Official Board
The organizational chart of Xilis displays its 7 main executives including Xiling Shen, Ryan Jones and Corey Evans. Toggle navigation The Official Board. Search. Search. Search by segment. …See details»
Xilis - Funding, Financials, Valuation & Investors - Crunchbase
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
xilis - LinkedIn
Xilis’ proprietary #MicroOrganoSphere™ (MOS) technology represents a new standard in patient-derived micro-tumor production. From each patient, MOS retains unique patient tissue structure ...See details»
Xilis - VentureRadar
Developed by world-class scientists from the U.S. and Europe, Xilis’ MicroOrganoSphereTM (MOS) technology and Precision Oncology Platform is transforming treatment choices in the …See details»
Xilis Company Profile - Office Locations, Competitors, Revenue
Xilis is a biotechnology company that specializes in the development of precision medicine and drug discovery technologies. It offers MicroOrganoSphere (MOS) technologies to guide …See details»
Our Founders & Our Story - Xilis
Xilis was founded in 2019 when the three founders -- an engineer, a physician and a biologist -- decided to develop and commercialize their technology to transform cancer care. As …See details»
Xilis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Xilis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... About. Xilis has 9 current employee profiles, including …See details»
Xilis - Pear VC
Xilis was founded in 2019 when its three founders — an engineer, a physician, and a biologist — decided to develop technology to transform cancer care. As leaders in their respective fields …See details»
Xilis - EQT Group
Micro-organoid technology for precision cancer therapy and improved drug discovery.See details»
Xilis, Inc. | Catalio Capital Management
Xilis is developing its patented MicroOrganoSpheres (MOS) technology to screen therapeutic interventions at the individual patient level and guide personalized therapy. Xilis’ MOS platform …See details»
Xilis - workinbiotech.com
Xilis is developing next-generation technologies to guide therapies for cancer patients. Current cancer therapies have side effects that could be eliminated if patient-specific responses could …See details»
Our Team - Xilis
Xilis B.V. Subsidiary of Xilis, Inc. Alessandro Cutilli. Junior Scientist Alessandro Cutilli. Junior Scientist Daisy Philips. Senior Research Associate Daisy Philips. Senior Research Associate …See details»
Alix Ventures — Xilis
Xilis “Xilis is developing a rapid and scalable patient-derived miniature-organoid technology platform to revolutionize precision medicine and pharmaceutical drug discovery. Our micro …See details»
Xilis Raises $70 Million Series A Financing to Advance ... - Duke OTC
Nasdaq highlights Xilis on their tower in Times Square. — Xilis’ MicroOrganoSphereTM (MOS) technology generates thousands of miniature patient- derived tumors that capture the original …See details»
Our Values - Xilis
At Xilis, we have an unwavering commitment to use our technology, skills, and time to provide patients with transformative new diagnostics and therapeutics. ... management of Xilis are …See details»
Tech Chief Regina Salazar Is Driving Digital Innovation At Novelis
1 day ago In 2024, Novelis launched Vision 3x30, a strategic framework with ambitious goals for 2030. Becoming a data-driven organization is a key enabler, and Salazar's team is advancing …See details»